For research use only. Not for therapeutic Use.
(S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77)[1].
| Catalog Number | I045649 |
| CAS Number | 1323077-88-8 |
| Synonyms | (3S)-4-(3-methyl-1,2-oxazole-4-carbonyl)-3-(6-methylpyridin-3-yl)-1,4,7-triazatricyclo[7.3.0.03,7]dodeca-9,11-dien-8-one |
| Molecular Formula | C20H19N5O3 |
| Purity | ≥95% |
| InChI | InChI=1S/C20H19N5O3/c1-13-5-6-15(10-21-13)20-12-23-7-3-4-17(23)19(27)25(20)9-8-24(20)18(26)16-11-28-22-14(16)2/h3-7,10-11H,8-9,12H2,1-2H3/t20-/m1/s1 |
| InChIKey | KUDXTBCRESIJFH-HXUWFJFHSA-N |
| SMILES | CC1=NC=C(C=C1)C23CN4C=CC=C4C(=O)N2CCN3C(=O)C5=CON=C5C |
| Reference | [1]. Jeffrey Peter Mitchell, et al. Compounds for treating respiratory syncytial virus infections. WO2011094823A1 |
